Cargando…
Inhibitory Effect of the HASPIN Inhibitor CHR-6494 on BxPC-3-Luc, A Luciferase-Expressing Pancreatic Cancer Cell Line
HASPIN acts in chromosome segregation via histone phosphorylation. Recently, HASPIN inhibitors have been shown to suppress growth of various cancer cells. Pancreatic cancer has no symptom in the early stages and may progress before detection. So, the 5-year survival rate is low. Here, we reported th...
Autores principales: | Tanaka, Hiromitsu, Nishida-Fukuda, Hisayo, Wada, Morimasa, Tokuhiro, Keizo, Matsushita, Hiroaki, Ando, Yukio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Royan Institute
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9124445/ https://www.ncbi.nlm.nih.gov/pubmed/35674022 http://dx.doi.org/10.22074/cellj.2022.7796 |
Ejemplares similares
-
Evaluation of the antiproliferative effects of the HASPIN inhibitor CHR-6494 in breast cancer cell lines
por: Nishida-Fukuda, Hisayo, et al.
Publicado: (2021) -
HASPIN kinase inhibitor CHR-6494 suppresses intestinal polyp development, cachexia, and hypogonadism in Apc(min/+) mice
por: Tanaka, Hiromitsu, et al.
Publicado: (2019) -
Anti-Melanoma Activities of Haspin Inhibitor CHR-6494 Deployed as a Single Agent or in a Synergistic Combination with MEK Inhibitor
por: Han, Lili, et al.
Publicado: (2017) -
Ingestion of Soybean Sprouts Containing a HASPIN Inhibitor Improves Condition in a Mouse Model of Alzheimer’s Disease
por: Tanaka, Hiromitsu, et al.
Publicado: (2023) -
Antiproliferative effect of alpinetin in BxPC-3 pancreatic cancer cells
por: DU, JIAN, et al.
Publicado: (2012)